Immune-related mirna-195-5p inhibits the progression of lung adenocarcinoma by targeting polypyrimidine tract-binding protein 1

HIGHLIGHTS

• who: Lincan Duan from the University of Kansas Medical Center, United States have published the research: Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1, in the Journal: (JOURNAL)
• what: The authors found that miR-195-5p expression was downregulation in LUAD, compared to normal tissues.
• how: The results showed that low expression of miRNA195-5p was related to good overall survival (OS) in BLCA KIRC and ovarian serous cystadenocarcinoma and associated with poor overall survival in BRCA LIHC LUAD LUSC sarcoma and UCEC . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.